BioCentury
ARTICLE | Financial News

RiverVest closes fourth life science venture fund

December 21, 2018 8:08 PM UTC

RiverVest Venture Partners announced the final close of RiverVest Venture Fund IV at $184.4 million.

The firm has invested in eight companies from the fund to date, including cancer company OncoResponse Inc. (Houston, Texas) and liver disease company Mirum Pharmaceuticals Inc. (San Francisco, Calif.) (see "OncoResponse to Move Into Clinic With $40M Series B"; "Mirum Launches With Liver Disease Candidates From Shire")...